product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
CD4 Antibody (RPA-T4) - Azide and BSA Free
catalog :
NBP2-25199
quantity :
0.1 mg (also 0.025 mg)
price :
359 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
RPA-T4
reactivity :
human
application :
immunohistochemistry, immunocytochemistry, neutralization, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
citations: 18
Reference
Zhang Q, Zong L, Zhang H, Xie W, Yang F, Sun W, et al. B7-H4 Expression in Precancerous Lesions of the Uterine Cervix. Biomed Res Int. 2021;2021:5857092 pubmed publisher
Radhakrishnan R, Thandi R, Tripathi D, Paidipally P, McAllister M, Mulik S, et al. BCG vaccination reduces the mortality of Mycobacterium tuberculosis-infected type 2 diabetes mellitus mice. JCI Insight. 2020;5: pubmed publisher
Steines L, Poth H, Schuster A, Geissler E, Amann K, Banas B, et al. Anti-BAFF Treatment Interferes With Humoral Responses in a Model of Renal Transplantation in Rats. Transplantation. 2020;104:e16-e22 pubmed publisher
Wang P, Qi X, Xu G, Liu J, Guo J, Li X, et al. CCL28 promotes locomotor recovery after spinal cord injury via recruiting regulatory T cells. Aging (Albany NY). 2019;11:7402-7415 pubmed publisher
Wang Z, Sun K, Xiao Y, Feng B, Mikule K, Ma X, et al. Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models. Sci Rep. 2019;9:1853 pubmed publisher
Ito M, Komai K, Mise Omata S, Iizuka Koga M, Noguchi Y, Kondo T, et al. Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery. Nature. 2019;565:246-250 pubmed publisher
Yu J, Bhattacharya S, Yanamandra N, Kilian D, Shi H, Yadavilli S, et al. Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments. PLoS ONE. 2018;13:e0206223 pubmed publisher
Jiang Y, Cao Z, Ma H, Wang G, Wang X, Wang Z, et al. Auricular Vagus Nerve Stimulation Exerts Antiinflammatory Effects and Immune Regulatory Function in a 6-OHDA Model of Parkinson's Disease. Neurochem Res. 2018;43:2155-2164 pubmed publisher
Meder L, Schuldt P, Thelen M, Schmitt A, Dietlein F, Klein S, et al. Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer. Cancer Res. 2018;78:4270-4281 pubmed publisher
Schmidt T, Solimani F, Pollmann R, Stein R, Schmidt A, Stulberg I, et al. Th1/Th17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in lichen planus. J Allergy Clin Immunol. 2018;: pubmed publisher
Petrizzo A, Mauriello A, Luciano A, Rea D, Barbieri A, Arra C, et al. Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting. Oncotarget. 2018;9:3576-3589 pubmed publisher
Samanta D, Park Y, Ni X, Li H, Zahnow C, Gabrielson E, et al. Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells. Proc Natl Acad Sci U S A. 2018;115:E1239-E1248 pubmed publisher
Sun J, Lian M, Ma H, Wang R, Ma Z, Wang H, et al. Competing endogenous RNA network analysis of CD274, IL‑10 and FOXP3 co‑expression in laryngeal squamous cell carcinoma. Mol Med Rep. 2018;17:3859-3869 pubmed publisher
Busch C, Annamalai B, Abdusalamova K, Reichhart N, Huber C, Lin Y, et al. Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium. Front Immunol. 2017;8:703 pubmed publisher
Varga M, Piazuelo M, Romero Gallo J, Delgado A, Suarez G, Whitaker M, et al. TLR9 activation suppresses inflammation in response to Helicobacter pylori infection. Am J Physiol Gastrointest Liver Physiol. 2016;311:G852-G858 pubmed publisher
Zhang M, Yao B, Wang Y, Yang S, Wang S, Fan X, et al. Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension. J Clin Invest. 2015;125:4281-94 pubmed publisher
Hellwinkel J, Redzic J, Harland T, Gunaydin D, Anchordoquy T, Graner M. Glioma-derived extracellular vesicles selectively suppress immune responses. Neuro Oncol. 2016;18:497-506 pubmed publisher
Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015;520:692-6 pubmed publisher
product information
master code :
NBP2-25199
SKU :
NBP2-25199
product name :
CD4 Antibody (RPA-T4) - Azide and BSA Free
unit size :
0.1 mg (also 0.025 mg)
description :
The CD4 Antibody (RPA-T4) - Azide and BSA Free from Novus is a mouse monoclonal antibody to CD4. This antibody reacts with human. The CD4 Antibody (RPA-T4) - Azide and BSA Free has been validated for the following applications: Flow Cytometry,Immunohistochemistry-Frozen,In vitro assay,Immunocytochemistry/ Immunofluorescence,Immunohistochemistry,Immunohistochemistry-Paraffin (Negative),CyTOF-ready,Block/Neutralize.
target :
CD4
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
RPA-T4
concentration :
1 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
PHA-stimulated human PBMC.
isotype :
IgG1 Kappa
purity :
Protein G purified
species :
Human
gene symbol :
CD4
accessionNumbers :
NP_000607
applications :
Flow Cytometry,Immunohistochemistry-Frozen,In vitro assay,Immunocytochemistry/ Immunofluorescence,Immunohistochemistry,Immunohistochemistry-Paraffin (Negative),CyTOF-ready,Block/Neutralize
extended description :
Clone RPA-T4 was used by HLDA to establish CD designation.
USD :
359 USD
product details :
Clone RPA-T4 was used by HLDA to establish CD designation.
alt names :
CD_antigen: CD4, CD4, CD4 antigen, CD4 antigen (p55), CD4 molecule, CD4 receptor, CD4mut, T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.